Data protection Impressum

Biotech

CDMOs play a crucial role in the pharmaceutical sector, serving as key partners in the drug development and production process.

Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings

16 October 2023

From left to right: Nicolas Weber, CEO of Voltiris, Nasri Nahas, CEO of Biopôle SA, Jonas Roch, CTO of Voltiris and Pierre-Jean Wipff, Innovation and Partnerships Director at Biopôle.

Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund

11 October 2023

PULSE, with its distinctive amalgamation of adaptable, future-proof infrastructure, is set to become a pivotal hub designed to uplift and expand the frontiers of biotech and various scientific ventures.

PULSE, a modular innovation center in the heart of the Health Valley

10 October 2023

Through this partnership, the synergy between academic excellence and pioneering biotherapeutic research is set to delineate new horizons in patient care, particularly in the field of tissue regeneration and repair.

Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine

10 October 2023

Lonza continues to fortify its position in ADC production, expanding collaboration and infrastructure to enhance its acclaimed Ibex Dedicate Biopark.

Lonza further extends its ADC manufacturing capabilities in Visp

9 October 2023

The Institute of Life Technologies of the HES-SO Valais/Wallis has forged a five-year collaboration with Debiopharm Research & Manufacturing to develop new targeted antibody fragment vectorization technologies.

HES-SO Valais-Wallis and Debiopharm partner up to battle cancer

4 October 2023

Nagi Bioscience is at the cusp of redefining the landscape of next-generation drug discovery and chemical testing technologies, placing humane testing solutions within arm’s reach of the global scientific community.

Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing

3 October 2023

With Atinary’s SDLabs, individuals or organizations can effortlessly incorporate ML into their existing workflows, with or without the utilization of robots, or in a simulation environment, to enhance and expedite R&D operations immediately.

Atinary Technologies raises USD 5 million to accelerate material and molecular innovation

3 October 2023

Top Stories Western Switzerland

Top Stories from Western Switzerland (July-September 2023)

27 September 2023

The Vaud-based biotech start-up, ranking first in the TOP 100 Swiss Startup Award 2023, harnesses the dark genome to craft precise RNA therapies for disease-modifying cell states.

HAYA Therapeutics triumphs at the 13th TOP 100 Swiss Startup Award

11 September 2023

1 … 11 12 13 14 15 16 17 18 19 … 24